SomnoMed Limited
Research SomnoMed Limited (RJV) on Bullrun: market cap EUR 48.79M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRJV
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 48.79M
- Financial periodFY2024
- RevenueAUD 91.65M
- Revenue growth9.6%
- Net income-AUD 12.24M
- Free cash flow-AUD 11.67M
- Gross margin60.2%
Valuation Snapshot
latest market cap is EUR 48.79M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | AUD 91.65M | -AUD 12.24M | -AUD 11.67M | 60.2% | -0.1 | AUD 16.18M | AUD 6.72M | AUD 45.91M |
| FY2023 | AUD 83.62M | -AUD 8.00M | -AUD 10.29M | 62.1% | -0.08 | AUD 11.96M | AUD 23.82M | AUD 24.51M |
| FY2022 | AUD 72.58M | -AUD 4.44M | -AUD 6.93M | 61.0% | -0.04 | AUD 15.64M | AUD 16.89M | AUD 27.79M |
| FY2021 | AUD 62.71M | -AUD 1.19M | -AUD 1.43M | 60.2% | -0.01 | AUD 21.11M | AUD 8.91M | AUD 32.16M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 48.79M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SomnoMed Limited's market cap?
SomnoMed Limited's market capitalization is EUR 48.79M.
What does SomnoMed Limited do?
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.